These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4988339)

  • 1. Antibacterial immunity induced by ribosomal vaccines.
    Winston SH; Berry LJ
    J Reticuloendothel Soc; 1970 Jul; 8(1):13-24. PubMed ID: 4988339
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity induced by ribosomal extracts from Staphylococcus aureus.
    Winston S; Berry LJ
    J Reticuloendothel Soc; 1970 Jul; 8(1):66-73. PubMed ID: 5432870
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of ribosomal preparations from Pseudomonas aeruginosa to protect against intravenous Pseudomonas challenge in mice.
    Smith RL; Wysocki JA; Bruun JN; De Courcy SJ; Blakemore WS; Mudd S
    J Reticuloendothel Soc; 1974 Jan; 15(1):22-30. PubMed ID: 4204145
    [No Abstract]   [Full Text] [Related]  

  • 4. Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.
    Lieberman MM; Ayala E
    J Immunol; 1983 Jul; 131(1):1-3. PubMed ID: 6408166
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
    Gonggrijp R; Mullers WJ; van Boven CP
    Infect Immun; 1981 Jul; 33(1):178-85. PubMed ID: 6167518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey).
    Joó I; Stanislavskii ES
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):417-27. PubMed ID: 6819316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonuclease-sensitive ribosomal vaccines.
    Gonggrijp R; Antonissen AC; van den Bosch JF; van Boven CP
    Antonie Van Leeuwenhoek; 1984; 50(5-6):763-74. PubMed ID: 6084981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.
    Lieberman MM
    Infect Immun; 1978 Jul; 21(1):76-86. PubMed ID: 101464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of chickens by ribosomal vaccines from Pasteurella multocida: dependence on homologous lipopolysaccharide.
    Phillips M; Rimler RB
    Am J Vet Res; 1984 Sep; 45(9):1785-9. PubMed ID: 6208828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomal vaccines: introduction to the study of ribosomal vaccines.
    Dussourd d'Hinterland L
    Arzneimittelforschung; 1980; 30(1a):122-5. PubMed ID: 6154466
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal vaccines: immunological study.
    Dussourd d'Hinterland L; Pinel AM; Rey G
    Arzneimittelforschung; 1980; 30(1a):132-41. PubMed ID: 6768371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenic value of some staphylococcal antigens.
    Wysokińska T
    Contrib Microbiol Immunol; 1973; 1():281-2. PubMed ID: 4805309
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigations on the efficacy of specific immunization with corpuscular vaccines in urinary tract infections with Pseudomonas aeruginosa or mixed bacteria.
    Neagu V; Meitert E; Ioanid CP; Racovită C; Găleşanu M; Sima F; Savulian C; Momiceanu D; Noica N; Neagoe M
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):39-52. PubMed ID: 6442131
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of experimental burn wound sepsis by postburn immunization with polyvalent Pseudomonas antigen.
    Nance FC; Hines JL; Fulton RE; Bornside GH
    Surgery; 1970 Jul; 68(1):248-53. PubMed ID: 10483476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells.
    Worgall S; Kikuchi T; Singh R; Martushova K; Lande L; Crystal RG
    Infect Immun; 2001 Jul; 69(7):4521-7. PubMed ID: 11401995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenic properties of the ribosomal fraction of Staphylococcus aureus].
    Wysokińska T
    Med Dosw Mikrobiol; 1977; 29(1):11-7. PubMed ID: 859369
    [No Abstract]   [Full Text] [Related]  

  • 19. [Investigations on the immunogenicity of Pseudomonas seruginosa strains of different serological O-groups].
    Meitert E; Meitert T
    Zentralbl Bakteriol Orig; 1968; 208(4):515-21. PubMed ID: 5000090
    [No Abstract]   [Full Text] [Related]  

  • 20. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
    Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA
    Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.